Quadrant Capital Group LLC Catalent, Inc. Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 681 shares of CTLT stock, worth $40,117. This represents 0.0% of its overall portfolio holdings.

Number of Shares

681

Previous 694 1.87%

Holding current value

$40,117

Previous $39,000 5.13%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$56.16 - $60.96 $730 - $792	-13 Reduced 1.87%	681 $41,000
Q2 2024 Aug 12, 2024	BUY	$53.58 - $57.02 $11,305 - $12,031	211 Added 43.69%	694 $39,000
Q1 2024 May 15, 2024	SELL	$42.56 - $59.82 $1,787 - $2,512	-42 Reduced 8.0%	483 $27,000
Q4 2023 Feb 08, 2024	SELL	$32.18 - $46.57 $3,829 - $5,541	-119 Reduced 18.48%	525 $23,000
Q3 2023 Nov 14, 2023	BUY	$44.2 - $50.2 $44 - $50	1 Added 0.16%	644 $29,000
Q2 2023 Aug 09, 2023	SELL	$31.86 - $67.26 $44,094 - $93,087	-1,384 Reduced 68.28%	643 $27,000
Q1 2023 May 11, 2023	BUY	$45.44 - $74.26 $20,675 - $33,788	455 Added 28.94%	2,027 $133,000
Q4 2022 Feb 10, 2023	BUY	$41.39 - $81.0 $4,263 - $8,343	103 Added 7.01%	1,572 $70,000
Q3 2022 Nov 10, 2022	BUY	$72.36 - $113.1 $4,196 - $6,559	58 Added 4.11%	1,469 $106,000
Q2 2022 Aug 09, 2022	BUY	$87.2 - $114.05 $10,028 - $13,115	115 Added 8.87%	1,411 $151,000
Q1 2022 May 06, 2022	SELL	$94.19 - $124.49 $13,940 - $18,424	-148 Reduced 10.25%	1,296 $144,000
Q4 2021 Feb 01, 2022	BUY	$119.57 - $139.07 $4,184 - $4,867	35 Added 2.48%	1,444 $185,000
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $11,681 - $15,231	107 Added 8.22%	1,409 $187,000
Q2 2021 Aug 09, 2021	BUY	$100.34 - $115.69 $13,545 - $15,618	135 Added 11.57%	1,302 $141,000
Q1 2021 May 12, 2021	BUY	$101.51 - $125.27 $10,861 - $13,403	107 Added 10.09%	1,167 $123,000
Q4 2020 Feb 16, 2021	SELL	$85.88 - $105.36 $10,477 - $12,853	-122 Reduced 10.32%	1,060 $110,000
Q3 2020 Nov 13, 2020	SELL	$72.74 - $92.5 $129,986 - $165,297	-1,787 Reduced 60.19%	1,182 $101,000
Q2 2020 Aug 13, 2020	BUY	$48.02 - $79.04 $39,616 - $65,208	825 Added 38.48%	2,969 $218,000
Q1 2020 May 15, 2020	BUY	$36.95 - $62.95 $8,535 - $14,541	231 Added 12.08%	2,144 $110,000
Q4 2019 Feb 03, 2020	BUY	$47.06 - $56.64 $188 - $226	4 Added 0.21%	1,913 $101,000
Q1 2019 Apr 29, 2019	BUY	$29.84 - $43.92 $41,358 - $60,873	1,386 Added 265.01%	1,909 $71,000
Q4 2018 Jan 17, 2019	BUY	$29.95 - $46.34 $628 - $973	21 Added 4.18%	523 $11,000
Q2 2018 Aug 09, 2018	SELL	$38.72 - $42.52 $6,311 - $6,930	-163 Reduced 24.51%	502 $17,000
Q1 2018 May 10, 2018	BUY	$39.4 - $47.39 $19,030 - $22,889	483 Added 265.38%	665 $24,000
Q3 2017 Oct 13, 2017	BUY	$33.75 - $41.67 $1,755 - $2,166	52 Added 40.0%	182 $6,000
Q2 2017 Aug 15, 2017	BUY	N/A	130	130 $3,000

Others Institutions Holding CTLT

# of Institutions

510

Shares Held

150M

Call Options Held

510K

Put Options Held

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.6B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Catalent, Inc. Transaction History